Volume 17, Issue 12, December 2015
Editorials
How neuronal activity regulates glioma cell proliferation
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1543–1544, https://doi.org/10.1093/neuonc/nov188
Translating preclinical hopes into clinical reality for children with ependymoma
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1545–1546, https://doi.org/10.1093/neuonc/nov240
Highlights from the Literature
Highlights from the Literature
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1547–1549, https://doi.org/10.1093/neuonc/nov279
Review
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1550–1559, https://doi.org/10.1093/neuonc/nov152
Basic and Translational Investigations
Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1560–1567, https://doi.org/10.1093/neuonc/nov049
Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1568–1577, https://doi.org/10.1093/neuonc/nov058
Transcriptional upregulation of microtubule-associated protein 2 is involved in the protein kinase A-induced decrease in the invasiveness of glioma cells
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1578–1588, https://doi.org/10.1093/neuonc/nov060
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1589–1598, https://doi.org/10.1093/neuonc/nov064
Fatty acid synthase is a metabolic oncogene targetable in malignant peripheral nerve sheath tumors
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1599–1608, https://doi.org/10.1093/neuonc/nov076
CLINICAL INVESTIGATIONS
Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1609–1619, https://doi.org/10.1093/neuonc/nov126
Pediatric Neuro-Oncology
Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1620–1627, https://doi.org/10.1093/neuonc/nov181
Screening for cognitive deficits in 8 to 14-year old children with cerebellar tumors using self-report measures of executive and behavioral functioning and health-related quality of life
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1628–1636, https://doi.org/10.1093/neuonc/nov129
Neuroimaging
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1637–1647, https://doi.org/10.1093/neuonc/nov099
Letter to the Editor
Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment?
Neuro-Oncology, Volume 17, Issue 12, December 2015, Pages 1648–1649, https://doi.org/10.1093/neuonc/nov246
Erratum
Erratum
Neuro-Oncology, Volume 17, Issue 12, December 2015, Page 1650, https://doi.org/10.1093/neuonc/nov201
Announcements
Society news
Neuro-Oncology, Volume 17, Issue 12, December 2015, Page 1651, https://doi.org/10.1093/neuonc/nov278
Cover/Standing Material
Cover Page
Neuro-Oncology, Volume 17, Issue 12, December 2015, Page NP, https://doi.org/10.1093/neuonc/nov293
Editorial Board
Neuro-Oncology, Volume 17, Issue 12, December 2015, Page NP, https://doi.org/10.1093/neuonc/nov294
Subscription Page
Neuro-Oncology, Volume 17, Issue 12, December 2015, Page NP, https://doi.org/10.1093/neuonc/nov295
Contents Page
Neuro-Oncology, Volume 17, Issue 12, December 2015, Page NP, https://doi.org/10.1093/neuonc/nov296
